This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on screening for depression and suicide risk in children and adolescents summarizes published evidence on the benefits and harms of screening for and treatment of depression and suicide risk in children and adolescents 18 years or younger.
Source: JAMA Online First